Physician

Jesus Vera Aguilera, M.D.

According to 2025 Medicare claims, Jesus Aguilera, M.D. (NPI: 1265872196) practices hematology/oncology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Hennepin, MN. This provider's primary affiliated billing organization is MINNESOTA ONCOLOGY HEMATOLOGY, PA (NPI: 1528035995; TIN: 411793418) and primary practice location at 55369-7588. Aguilera is affiliated with the Essentia Health ACO, Inc. (ACO ID: A5617), participating under the MSSP model.

Aguilera's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 374 traditional Medicare patients, billed 119,702 HCPCS/CPT codes, and received $2,136,219 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 924 prescription claims across 200 beneficiaries totaling $2,615,916 in drug costs, led by Jakafi (Ruxolitinib Phosphate). 2023 DME data shows 13 claims. Open Payments data shows 5 records totaling $8,085. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,652 to $2,136,219. Similarly, Part D prescription costs have moved sharply higher in recent years, from $19,398 to $2,615,916. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	26	32	$2,652
2017	29	60	$5,032
2018	38	90	$7,804
2019	96	206	$14,150
2020	162	478	$31,918
2021	184	645	$60,692
2022	194	651	$59,949
2023	281	29,983	$661,947
2024	374	119,702	$2,136,219

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	27	274	$19,398
2016	54	590	$38,351
2017	36	87	$53,367
2018	16	48	$78,793
2019	77	270	$155,917
2020	166	758	$1,203,418
2021	215	1,303	$1,843,939
2022	219	1,270	$2,584,456
2023	210	1,073	$2,377,236
2024	200	924	$2,615,916

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	24	$2,299
2021	N/R	34	$2,316
2022	N/R	16	$302
2023	N/R	13	$3,484
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	108	249	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	118	229	$95
80053	Blood test, comprehensive group of blood chemicals	120	382	$10
36415	Insertion of needle into vein for collection of blood sample	109	326	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	123	480	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	29	870	$448,534
Revlimid	Lenalidomide	18	532	$327,011
Xtandi	Enzalutamide	16	480	$231,144
Promacta	Eltrombopag Olamine	11	330	$198,915
Eliquis	Apixaban	36	1,415	$27,317

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$8,085	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jesus Vera Aguilera, M.D.?

Tedicare shows public-source Medicare data for Jesus Vera Aguilera, M.D. (NPI 1265872196), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jesus Vera Aguilera, M.D. have ACO affiliation data?

Jesus Vera Aguilera, M.D. is shown with ACO affiliation data for Essentia Health ACO, Inc. (MSSP, ACO ID A5617).

What billing organization is linked to Jesus Vera Aguilera, M.D.?

Jesus Vera Aguilera, M.D. is linked to MINNESOTA ONCOLOGY HEMATOLOGY, PA (billing NPI 1528035995) in the available physician profile data.

Does Jesus Vera Aguilera, M.D. have Open Payments data?

Jesus Vera Aguilera, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.